The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy
Abstract
Evidence implicates hyperglycemia-derived oxygen free radicals as mediators of diabetic complications. However, intervention studies with classic antioxidants, such as vitamin E, failed to demonstrate any beneficial effect. Recent studies demonstrate that a single hyperglycemia-induced process of overproduction of superoxide by the mitochondrial electron-transport chain seems to be the first and key event in the activation of all other pathways involved in the pathogenesis of diabetic complications. These include increased polyol pathway flux, increased advanced glycosylation end product formation, activation of protein kinase C, and increased hexosamine pathway flux. Superoxide overproduction is accompanied by increased nitric oxide generation, due to an endothelial NOS and inducible NOS uncoupled state, a phenomenon favoring the formation of the strong oxidant peroxynitrite, which in turn damages DNA. DNA damage is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP-ribose) polymerase. Poly(ADP-ribose) polymerase activation in turn depletes the intracellular concentration of its substrate NAD+, slowing the rate of glycolysis, electron transport, and ATP formation, and produces an ADP-ribosylation of the GAPDH. These processes result in acute endothelial dysfunction in diabetic blood vessels that, convincingly, also contributes to the development of diabetic complications. These new findings may explain why classic antioxidants, such as vitamin E, which work by scavenging already-formed toxic oxidation products, have failed to show beneficial effects on diabetic complications and may suggest new and attractive “causal” antioxidant therapy. New low–molecular mass compounds that act as SOD or catalase mimetics or l-propionyl-carnitine and lipoic acid, which work as intracellular superoxide scavengers, improving mitochondrial function and reducing DNA damage, may be good candidates for such a strategy, and preliminary studies support this hypothesis. This “causal” therapy would also be associated with other promising tools such as LY 333531, PJ34, and FP15, which block the protein kinase β isoform, poly(ADP-ribose) polymerase, and peroxynitrite, respectively. While waiting for these focused tools, we may have other options: thiazolinediones, statins, ACE inhibitors, and angiotensin 1 inhibitors can reduce intracellular oxidative stress generation, and it has been suggested that many of their beneficial effects, even in diabetic patients, are due to this property.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanisms underlying the biological effects of statins and AT-1 receptor blockers differ, even in terms of intracellular antioxidant activity.”
In the citing paper
“Statins and AT-1 receptor blockers protect endothelial function and reduce inflammation in diabetic and nondiabetic subjects, and these effects are convincingly mediated through their intracellular antioxidant activity.”
In the citing paper
“Although this review is concerned with mitochondrial ROS, it should be recognized that considerable ROS derives from outside this organelle, including oxygen radicals from peroxisomal β-oxidation of fatty acids (24), NAD(P)H oxidase (53), xanthine oxidase, arachidonic acid metabolism, microsomal P-450 enzymes (75), and the prooxidant heme molecule (226).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [53]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Nitric oxide synthases: Roles, tolls, and controls
Nathan, C., & Xie, Q. W. (1994) · Cell · doi:10.1016/0092-8674(94)90266-6 · Cited by 2,920
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,527
(2000) · PubMed · Cited by 2,095
Oxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,921
Self-citationLindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,274
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M. P., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,191
Endothelial dysfunction in diabetes
De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703393 · Cited by 1,165
Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H. J., Ziyadeh, F. N., Wu, J., & Brownlee, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12222 · Cited by 1,152
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,117
Cuzzocrea, S., Riley, D. P., Caputi, A. P., & Salvemini, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01484-4 · Cited by 1,087
Ischiropoulos, H. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0755 · Cited by 1,025
Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus
Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R. G., & Channon, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000012748.58444.08 · Cited by 979
McVeigh, G. E., Brennan, G. M., Johnston, G. D., McDermott, B. J., McGrath, L. T., Henry, W. R., Andrews, J. W., & Hayes, J. R. (1992) · Diabetologia · doi:10.1007/bf00429099 · Cited by 916
Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., & Brownlee, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11235 · Cited by 907
Ting, H. H., Timimi, F. K., Boles, K., Creager, S. J., Ganz, P., & Creager, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118394 · Cited by 869
Myocardial Cell Death in Human Diabetes
Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Leri, A., Maseri, A., Nadal-Ginard, B., & Anversa, P. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1123 · Cited by 796
Cosentino, F., Hishikawa, K., Katušić, Z. S., & Lüscher, T. F. (1997) · Circulation · doi:10.1161/01.cir.96.1.25 · Cited by 762
Hyperglycemia and cardiovascular disease in type 2 diabetes.
Laakso, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.937 · Cited by 745
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
Chaturvedi, N., Sjolie, A.-K., Stephenson, J., Abrahamian, H., Keipes, M., Castellarin, A., Rogulja-Pepeonik, Ž., & Fuller, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06209-0 · Cited by 738
Kawano, H., Motoyama, T., Hirashima, O., Hirai, N., Miyao, Y., Sakamoto, T., Kugiyama, K., Ogawa, H., & Yasue, H. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00168-0 · Cited by 676
Ceriello, A., Taboga, C., Tonutti, L., Quagliaro, L., Piconi, L., Bais, B., Da Ros, R., & Motz, E. (2002) · Circulation · doi:10.1161/01.cir.0000027569.76671.a8 · Cited by 655
Self-citationZou, M., Shi, C., & Cohen, R. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14442 · Cited by 613
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
Soriano, F. G., Virág, L., Jagtap, P. G., Szabó, É., Mabley, J. G., Liaudet, L., Marton, A., Hoyt, D. G., Murthy, K. G. K., Salzman, A. L., et al. (2001) · Nature Medicine · doi:10.1038/83241 · Cited by 602
Oliver, F. J., Murcia, J. M., Nacci, C., Decker, P., Andriantsitohaina, R., Muller, S., de la Rubia, G., Stoclet, J., & de MURCIA, G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4446 · Cited by 583
Free radicals mediate endothelial cell dysfunction caused by elevated glucose
Tesfamariam, B., & Cohen, R. A. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.2.h321 · Cited by 558
Molecular aspects of lipoic acid in the prevention of diabetes complications
Packer, L., Kraemer, K., & Rimbach, G. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00658-x · Cited by 556
Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.
Collins, T. (1993) · PubMed · Cited by 524
Zou, M.-H., Shi, C., & Cohen, R. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214442 · Cited by 494
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M. F., Takemoto, Y., Kitakaze, M., & Liao, J. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13350 · Cited by 485
Enzymic mechanisms of superoxide production
Cross, A. R., & Jones, O. T. G. (1991) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(05)80140-9 · Cited by 468
Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress
Mercuri, F., Tonutti, L., Taboga, C., Ceriello, A., Assaloni, R., Motz, E., & Quagliaro, L. (2001) · Diabetologia · doi:10.1007/s001250100529 · Cited by 418
Self-citationBaek, K. J., Thiel, B. A., Lucas, S., & Stuehr, D. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36901-7 · Cited by 389
Kajstura, J., Fiordaliso, F., Andreoli, A. M., Li, B., Chimenti, S., Medow, M. S., Limana, F., Nadal‐Ginard, B., Leri, A., & Anversa, P. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1414 · Cited by 384
Li, M., Pascual, G., & Glass, C. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4699-4707.2000 · Cited by 377
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB
Onozato, M. L., Tojo, A., Goto, A., Fujita, T., & Wilcox, C. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00123.x · Cited by 374
The AT 1 -Type Angiotensin Receptor in Oxidative Stress and Atherogenesis
Nickenig, G., & Harrison, D. G. (2002) · Circulation · doi:10.1161/hc0302.102618 · Cited by 367
Giugliano, D., Marfella, R., Coppola, L., Verrazzo, G., Acampora, R., Giunta, R., Nappo, F., Lucarelli, C., & D’Onofrio, F. (1997) · Circulation · doi:10.1161/01.cir.95.7.1783 · Cited by 360
Zingarelli, B., Salzman, A. L., & Szabó, C. (1998) · Circulation Research · doi:10.1161/01.res.83.1.85 · Cited by 337
Ascorbate Restores Endothelium-Dependent Vasodilation Impaired by Acute Hyperglycemia in Humans
Beckman, J. A., Goldfine, A. B., Gordon, M. B., & Creager, M. A. (2001) · Circulation · doi:10.1161/01.cir.103.12.1618 · Cited by 314
Coppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., Lund, D. D., & Yorek, M. A. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1927 · Cited by 300
Zhang, H. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00183-2 · Cited by 296
Pacher, P., Liaudet, L., Soriano, F. G., Mabley, J. G., Szabó, É., & Szabó, C. (2002) · Diabetes · doi:10.2337/diabetes.51.2.514 · Cited by 281
Acute Hyperglycemia Induces Nitrotyrosine Formation and Apoptosis in Perfused Heart From Rat
Ceriello, A., Quagliaro, L., D’Amico, M., Filippo, C. D., Marfella, R., Nappo, F., Berrino, L., Rossi, F., & Giugliano, D. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1076 · Cited by 278
Self-citationBeckman, J. A., Goldfine, A. B., Gordon, M. B., Garrett, L. A., & Creager, M. A. (2002) · Circulation Research · doi:10.1161/hh0102.102359 · Cited by 276
Szabó, C., Virág, L., Cuzzocrea, S., Scott, G. S., Hake, P. W., O’Connor, M., Zingarelli, B., Salzman, A. L., & Kun, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3867 · Cited by 262
Role of Hyperglycemia in Nitrotyrosine Postprandial Generation
Ceriello, A., Quagliaro, L., Catone, B., Pascon, R., Piazzola, M., Bais, B., Marra, G., Tonutti, L., Taboga, C., & Motz, E. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1439 · Cited by 257
Self-citationTsunekawa, T., Hayashi, T., Kano, H., Sumi, D., Matsui‐Hirai, H., Thakur, N. K., Egashira, K., & Iguchi, A. (2001) · Circulation · doi:10.1161/hc2901.094094 · Cited by 256
Virág, L., Salzman, A. L., & Szabó, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3753 · Cited by 246
Acute hyperglycemia induces an oxidative stress in healthy subjects
Marfella, R., Quagliaro, L., Nappo, F., Ceriello, A., & Giugliano, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13727 · Cited by 242
Self-citationAre ACE Inhibitors a “Magic Bullet” Against Oxidative Stress?
Münzel, T. F., & Keaney, J. F. (2001) · Circulation · doi:10.1161/hc3801.095585 · Cited by 228
Obesity and cardiovascular disease: The Framingham study
Gordon, T., & Kannel, W. B. (1976) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(76)80026-6 · Cited by 210
Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.
Ceriello, A., Morocutti, A., Mercuri, F., Quagliaro, L., Moro, M., Damante, G., & Viberti, G. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2170 · Cited by 209
Self-citationEndothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals
Diederich, D. A., Skopec, J., Diederich, A., & Dai, F. X. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.3.h1153 · Cited by 199
L-Propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector
Vanella, A., Russo, A., Acquaviva, R., Campisi, A., Giacomo, C. D., Sorrenti, V., & Barcellona, M. L. (2000) · Cell Biology and Toxicology · doi:10.1023/a:1007638025856 · Cited by 194
Heitzer, T. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00551-2 · Cited by 194
Soriano, F. G., Pacher, P., Mabley, J. G., Liaudet, L., & Szabó, C. (2001) · Circulation Research · doi:10.1161/hh2001.097797 · Cited by 190
Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia
Sen, K., Misra, A., Kumar, A., & Pandey, R. M. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00341-2 · Cited by 185
Waßmann, S., Bäumer, A. T., Strehlow, K., van Eickels, M., Grohé, C., Ahlbory, K., Rösen, R., Böhm, M., & Nickenig, G. (2001) · Circulation · doi:10.1161/01.cir.103.3.435 · Cited by 181
Szabó, C., Mabley, J. G., Moeller, S. M., Shimanovich, R., Pacher, P., Virág, L., Soriano, F. G., van Duzer, J. H., Williams, W., Salzman, A. L., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402167 · Cited by 175
Marchioli, R., Schweiger, C., Levantesi, G., Tavazzi, L., & Valagussa, F. (2001) · Lipids · doi:10.1007/s11745-001-0683-y · Cited by 174
Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus
Mayhan, W. G. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.256.3.h621 · Cited by 170
Varin, R., Mulder, P. G. H., Tamion, F., Richard, V. J., Henry, J., Lallemand, F., Lerebours, G., & Thuillez, C. (2000) · Circulation · doi:10.1161/01.cir.102.3.351 · Cited by 157
Soriano, F. G., Virág, L., & Szabó, C. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100236 · Cited by 157
Endothelium-Dependent Relaxation in Aorta of BB Rat
Meraji, S., Jayakody, L., SENARATNE, M. P. J., Thomson, A. B. R., & Kappagoda, T. C. (1987) · Diabetes · doi:10.2337/diab.36.8.978 · Cited by 155
Pennathur, S., Wagner, J. D., Leeuwenburgh, C., Litwak, K. N., & Heinecke, J. W. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11194 · Cited by 153
Vascular targets of redox signalling in diabetes mellitus
Spitaler, M. M., & Graier, W. F. (2002) · Diabetologia · doi:10.1007/s00125-002-0782-0 · Cited by 149
Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles
Bohlen, H. G., & Lash, J. M. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.1.h219 · Cited by 145
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects
Marfella, R., Verrazzo, G., Acampora, R., La Marca, C., Giunta, R., Lucarelli, C., Paolisso, G., Ceriello, A., & Giugliano, D. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.6.e1167 · Cited by 129
Self-citationPacker, L., Valenza, M., Serbinova, E. A., Starke-Reed, P. E., Frost, K., & Kagan, V. E. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90231-7 · Cited by 118
Shiojiri, T., Wada, K., Nakajima, A., Katayama, K., Shibuya, A., Kudo, C., Kadowaki, T., Mayumi, T., Yura, Y., & Kamisaki, Y. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01946-5 · Cited by 111
Nitrotyrosine Causes Selective Vascular Endothelial Dysfunction and DNA Damage
Mihm, M. J., Liang, J., & Bauer, J. A. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200008000-00007 · Cited by 107
Park, K. S., Kim, J. H., Kim, M., Kim, J. M., Kim, S. K., Choi, J. Y., Chung, M. H., Han, B., Kim, S. Y., & Lee, H. K. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2837 · Cited by 107
Christ, M., Bauersachs, J., Liebetrau, C., Heck, M., Günther, A., & Wehling, M. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2648 · Cited by 107
Kowluru, A. (2001) · Acta Diabetologica · doi:10.1007/s592-001-8076-6 · Cited by 106
Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells
Brodsky, S. V., Gao, S., Li, H., & Goligorsky, M. S. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00196.2002 · Cited by 92
Nassar, T., Kadery, B., Lotan, C., Da’as, N., Kleinman, Y., & Haj-Yehia, A. I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01566-7 · Cited by 92
Coppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., Lund, D. D., Salvemini, D., & Yorek, M. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704216 · Cited by 91
Endothelium-dependent relaxation in aorta of BB rat
Meraji, S., Jayakody, L., SENARATNE, M. P. J., et al. (1987) · Diabetes · doi:10.2337/diabetes.36.8.978 · Cited by 77
Statin-stimulated nitric oxide release from endothelium.
Dobrucki, L. W., Kalinowski, L., Dobrucki, I. T., & Maliñski, T. (2001) · PubMed · Cited by 76
Hyperglycemia modulates angiotensinogen gene expression
Gabriely, I., Yang, X. M., Cases, J. A., Xiao, H., Rossetti, L., & Barzilai, N. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.3.r795 · Cited by 57
Felix, C. A., Gillis, M., Driedzic, W. R., Paulson, D. J., & Broderick, T. L. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00240-6 · Cited by 31
Broderick, T. L. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0031 · Cited by 28
Kamoshima, W., Kitamura, Y., Nomura, Y., & Taniguchi, T. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00091-5 · Cited by 28
Cotter, M. A., Cameron, N. E., Keegan, A., & Dines, K. C. (1995) · Metabolism · doi:10.1016/0026-0495(95)90018-7 · Cited by 25
Angiotensin-Receptor Blockers, Type 2 Diabetes, and Renoprotection
(2002) · New England Journal of Medicine · doi:10.1056/nejm200202283460912 · Cited by 16
Self-citationHypertension and ascorbic acid
Ness, A., & Sterne, J. A. C. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02101-2 · Cited by 11
Hypertension and ascorbic acid
Rolla, G., Brussino, L., Carra, R., Garbella, E., & Bucca, C. B. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74698-5 · Cited by 7
Cited by
Sorted by citations
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Ceriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378
Self-citationDiabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-5 · Cited by 1,024
Postprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945
Self-citation
Metadata
- Authors
- Ceriello, A.
- Affiliations
- University of Udine (IT)
- Corresponding author
- Ceriello, Antonio
- ORCID
- Ceriello, Antonio
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2003-05-01
- Volume
- 26
- Issue
- 5
- Pages
- 1589-1596
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2058550328
- Cited by
- 734
- References
- 102
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 16 · 2023: 15 · 2022: 16 · 2021: 24 · 2020: 13 · 2019: 27 · 2018: 34 · 2017: 41 · 2016: 33 · 2015: 34 · 2014: 46 · 2013: 49 · 2012: 50
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, diabetes complications, superoxide, mitochondrial electron transport chain, hyperglycemia, polyol pathway, advanced glycation end products, protein kinase C, hexosamine biosynthetic pathway, nitric oxide, peroxynitrite, DNA damage, poly(ADP-ribose) polymerase, NAD+ depletion, endothelial dysfunction, antioxidant therapy, superoxide dismutase mimetic, catalase mimetics, alpha-lipoic acid, PJ34, thiazolidinediones, statins, ACE inhibitors, angiotensin receptor blockers
- MeSH terms
- Antioxidants, Diabetes Mellitus, DNA Damage, Endothelium, Vascular, Humans, Hyperglycemia, Models, Biological, Oxidative Stress, Peroxynitrous Acid, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review